The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient concerns and disruptions in cancer care during the COVID-19 pandemic.
 
Erica E. Fortune
Research Funding - Boston Scientific Foundation (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pfizer (Inst); Takeda Science Foundation (Inst)
 
Jemeille Ackourey
No Relationships to Disclose
 
Thomas William LeBlanc
Honoraria - Abbvie; Astellas Pharma
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Flatiron Health; Pfizer; Seagen
Speakers' Bureau - Abbvie; Agios; Bristol-Myers Squibb; Celgene
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Jazz Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate Inc., royalty
Travel, Accommodations, Expenses - Abbvie/Genentech; Agios; Celgene
 
Heather Badt
Consulting or Advisory Role - Athenex (Inst)
Research Funding - Acceleron Pharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Janssen/Pharmacyclics (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pharmacyclics (Inst); Taiho Oncology (Inst); Takeda (Inst); The Anschutz Foundation (Inst)
(OPTIONAL) Uncompensated Relationships - Penn Med Patient and Family Advisory Council
 
Alexandra Katherine Zaleta
Research Funding - Astellas Pharma (Inst); Athenex (Inst); Gilead Sciences (Inst); Pfizer (Inst); Seagen (Inst)